David Beckham The company has now become a shareholder. PreneticsAs the English Former footballer and businessman, makes a “strategic” Investment to launch a health-and-wellness brand called IM8 in partnership with the Hong Kong Genetic profiling service provider.

IM8 will be focusing on “cutting-edge” Consumer health products Nasdaq-listed Prenetics In a press release, the company did not disclose any financial information. Beckham’s investment. Details The company has announced that IM8 will announce its products at a later date.

“Throughout my life and career, I’ve been fortunate to have access to the best medical professionals, nutrition experts, and fitness coaches. Their guidance has been crucial to my health and well-being,” Beckham In a statement, it was said. “I am excited to be partnering with Prenetics – a company that is dedicated to innovative, best-in-class scientific advancements in health.”

The Partner marks “transformative era” You can also find out more about the following: Prenetics The company’s chief executive officer and co-founder, Mr. Robert Cossu, has said that the company is a leader in global health innovations and wellness. Danny YeungYou can add that Beckham’s Display of discipline, teamwork and health are aligned Prenetics’ core principles.

Prenetics’ Co-founder, chief executive officer Danny Yeung Former footballer (left) David Beckham (right) following a discussion in London The following are some examples of how to use June 2024. Photo: Prenetics.

Prenetics You can also read about the importance of this in our article Beckham The company has met its shareholders Dennis Lo Yuk-ming is the director of Li Ka Shing Institute You can also find out more about the following: Health Sciences Professor of Chemical Pathology at the Chinese University You can also find out more about the following: Hong Kong.

“This meeting highlighted the significant potential of Prenetics’ innovations to impact global health and longevity,” Prenetics said.

In 1997, Lo The presence of fetal dna in maternal plasma was discovered, allowing for the pioneering use such markers for noninvasive prenatal diagnostics.

He The liquid biopsy of cancer has also been pioneered, particularly for the detection of nasopharyngeal cancer and the screening of various types of cancer.

Founded a decade ago, Prenetics The company has grown since its small beginnings Hong Kong A genetic testing lab to a company which also offers cancer screening services to help doctors prescribe targeted treatments to treat specific cancer types. It The company also operates in the UK. Taiwan, Japan The following are some examples of how to get started: Southeast Asia.

In In 2022, the majority of its shares were purchased. TaiwanACT-based GenomicsThe company offers a range of genomic tests that can be used to diagnose, treat and monitor cancer patients.

Prenetics A US$200 Million venture was established last July At the moment, Hong Kong Science The following are some examples of how to get started: Technology Park To develop and commercialise Lo’s The patented multi-cancer early diagnosis technology is called “FRAGMA”.

The Venture, also called Insighta, which aims to provide clinically-administered blood tests for early cancer cells in the lungs, liver, and other organs.

PreneticsThe net loss for the year was US$64.8m, down from US$190.5m in 2022. Revenue grew by 65 percent to US$21.7m.

During The pandemic of coronavirus. Prenetics It was the only Hong Kong-based laboratory was appointed by the city government during the first phase community Covid-19 testing across high-risk clusters. It The company is one of the leading providers of CovidRapid Test Kits – 19 Hong Kong.

Source link